Molecule Name |
DB09076
|
DrugBank Groups |
Approved
|
Cluster No |
1087
|
Smiles |
O(CC1(=CC=CC=C1))CCN45(CCC(C(O)(C2(=CC=CC=C2))C3(=CC=CC=C3))(CC4)CC5)
|
Download |
mol2, pdbqt
|
TPSA |
32,7
|
Non-H Atoms |
32
|
Non-C/H Atoms |
3
|
Metal-Atoms |
0
|
Electronegative Atoms |
3
|
Stereo Centers |
0
|
Rotatable Bonds |
8
|
Rings Closures |
5
|
Small Rings |
6
|
Aromatic Rings |
3
|
Aromatic Atoms |
18
|
sp3-Atoms |
14
|
Symmetric atoms |
14
|
cLogS |
-4,071
|
MW |
428,594
|
cLogP |
3,4351
|
HBA |
3
|
HBD |
1
|
Ro5 violations |
0
|
Druglikeness |
5,0746
|
DrugScore |
0,665287525051309
|
Mutagenic |
none
|
Tumorigenic |
none
|
Reproductive Effective |
none
|
Irritant |
none
|
Blood-Brain Barrier |
BBB+
|
Human Intestinal Absorption |
HIA-
|
Caco-2 Permeability |
Caco2+
|
P-glycoprotein Substrate |
Substrate
|
P-glycoprotein Inhibitor |
Inhibitor
|
P-glycoprotein Inhibitor 2 |
Inhibitor
|
Renal Organic Cation Transporter |
Inhibitor
|
Aqueous solubility |
-2,3472
|
Caco-2 Permeability 2 |
1,1724
|
Subcellular localization |
Mitochondria
|
CYP450 2C9 Substrate |
Non-substrate
|
CYP450 2D6 Substrate |
Non-substrate
|
CYP450 3A4 Substrate |
Non-substrate
|
CYP450 1A2 Inhibitor |
Non-inhibitor
|
CYP450 2C9 Inhibitor |
Non-inhibitor
|
CYP450 2D6 Inhibitor |
Inhibitor
|
CYP450 2C19 Inhibitor |
Non-inhibitor
|
CYP450 3A4 Inhibitor |
Non-inhibitor
|
CYP Inhibitory Promiscuity |
Low CYP Inhibitory Promiscuity
|
Human Ether-a-go-go-Related Gene Inhibition |
Strong inhibitor
|
Human Ether-a-go-go-Related Gene Inhibition 2 |
Inhibitor
|
AMES Toxicity |
Non AMES toxic
|
Carcinogens |
Non-carcinogens
|
Fish Toxicity |
Low FHMT
|
Fish Toxicity (pLC50, mg/L) |
2,2024
|
Tetrahymena Pyriformis Toxicity |
High TPT
|
Tetrahymena Pyriformis Toxicity (pIGC50, ug/L) |
0,2538
|
Honey Bee Toxicity |
Low HBT
|
Biodegradation |
Ready biodegradable
|
Acute Oral Toxicity |
III
|
Rat Acute Toxicity (LD50, mol/kg) |
2,9191
|
Carcinogenicity (Three-class) |
Non-required
|